Status:
NOT_YET_RECRUITING
Revealing Engagement Patterns Among Hepatic Encephalopathy Patients
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Hepatic Encephalopathy
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in hepatic encephalopathy clinical trials. Uncovering these factors is ess...
Eligibility Criteria
Inclusion
- Signed Written Informed Consent
- Aged ≥ 18 years old
- No prior treatment for hepatic encephalopathy
Exclusion
- Participant is actively receiving study therapy in another
- Inability to provide written informed consent
- Women of childbearing potential without a negative pregnancy test; or women who are lactating.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06201988
Start Date
January 1 2025
End Date
January 1 2027
Last Update
February 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107